Cerner Receives FDA Clearance for Fetal Monitoring Solution

KANSAS CITY, Mo., Oct. 5, 2009 (GLOBE NEWSWIRE) -- Despite advances in
technology and medical record keeping, most patient records are missing an
important piece of data. Currently, fetal monitoring waveform data gathered
throughout a woman's pregnancy is either kept on paper or in a separate system
outside of the electronic health record (EHR). Fetal waveforms capture important
data such as irregular infant heartbeats and history of distress that can be
used to help identify health problems, but that data is often not easily
accessible for clinicians. To solve this problem, Cerner (Nasdaq:CERN) developed
the Cerner FetaLink(TM) solution to integrate fetal and maternal monitoring
waveform data in the EHRs of the mother and the child. The Cerner FetaLink
solution recently received 510(k) pre-market clearance from the U.S. Food and
Drug Administration (FDA) and is now available in the United States and all U.S.
territories.

(Tweet this: Cerner receives FDA 510(k) for FetaLink maternal and fetal
monitoring solution http://bit.ly/cernPR)

"The Cerner FetaLink(TM) solution allows us to capture critical data about a
woman's pregnancy within the electronic health record so clinicians can make
informed decisions to protect the health of the baby and mother," said Joan
Hicks, chief information officer at UAB Hospital, a testing partner for the
Cerner FetaLink solution. "The ability for providers to view this critical data
in real-time not only in the hospital, but also in a clinic or remotely from the
physician's home, will help us provide better care to expectant mothers."

The Cerner FetaLink solution electronically documents and provides a graphical
display of the relationship between fetal heart rates and contraction data in
the EHR. It also stores and displays waveforms and annotations, which can be
viewed in real-time by care providers in inpatient or outpatient settings.
Clinicians can compare waveform data from different visits during a woman's
pregnancy, or even waveform data from the same patient's previous pregnancies to
determine whether current observations for a patient are within the normal range
for their pregnancy.

"The data generated during a woman's pregnancy contains valuable information
about the child and mother that can help clinicians provide better, safer care
to their patients," said Trace Devanny, Cerner president. "By connecting fetal
monitoring devices to the electronic health record, the Cerner FetaLink solution
is helping to build a Single Source of Truth(TM) for patient medical data in the
lifetime record."

The Cerner FetaLink solution, along with the Cerner PowerChart Maternity(TM)
solution, helps populate lifetime EHRs for the mother and the baby, gathering
data even before a baby is born. A fully integrated maternity solution benefits
clinicians and their patients by:

* Providing real-time access to critical information about a woman's
pregnancy and the health of her baby, improving patient safety and
helping clinicians make informed decisions;

* Allowing clinicians to compare historical pregnancy data that can
be used to evaluate the health of subsequent pregnancies; and

* Reducing medical errors associated with illegible handwriting and
transcription inaccuracies.
Cerner is the only healthcare supplier that provides a solution to seamlessly
integrate the maternal record across inpatient and outpatient venues.

About Cerner

Cerner is transforming healthcare by eliminating error, variance and waste for
healthcare providers and consumers around the world. Cerner(R) solutions
optimize processes for healthcare organizations ranging in size from
single-doctor practices, to health systems, to entire countries, for the
pharmaceutical and medical device industries, and for the healthcare commerce
system. These solutions are licensed by more than 8,000 facilities around the
world, including approximately 2,100 hospitals; 3,300 physician practices
covering more than 30,000 physicians; 500 ambulatory facilities, such as
laboratories, ambulatory centers, cardiac facilities, radiology clinics and
surgery centers; 600 home-health facilities; and 1,500 retail pharmacies. The
following are trademarks of Cerner: Cerner, Cerner's logo, FetaLink, PowerChart
Maternity and Single Source of Truth. (Nasdaq:CERN). For more information about
Cerner, please visit our Web site at www.cerner.com.

-0-
CONTACT: Cerner
Media Contact:
Sarah Bond
(816) 885-8020
sarah.bond@cerner.com
Investors Contact:
Allan Kells
(816) 201-2445
akells@cerner.com